The 8 Biggest Controversies In Martha Stewart's Career - Tasting Table
Briefly

The 8 Biggest Controversies In Martha Stewart's Career - Tasting Table
"Martha Stewart is, without a doubt, one of the most iconic business moguls in America. The New Jersey-born tastemaker began her career as a model and stockbroker before making a fortune teaching others how to cook, host, and create beautiful homes through her extensive catalog of cookbooks, magazines, TV shows, and product lines. There's no doubt that Stewart, who became America's first female self-made billionaire in 1999, has lived a truly fascinating life."
"However, wherever there's fame, money, success, and power, controversy is often not far behind - and Stewart is no exception. Over the years, she has weathered some serious ups and downs. In 2004, of course, Stewart even went to prison for a short spell, but that's not the only incident that has stirred up contention. Find out about some of Stewart's biggest controversies below - including details about her rocky relationship with her daughter, her extramarital affairs, highly questionable friendships, and financial transgressions."
"We can't talk about Martha Stewart's controversies without mentioning the insider trading scandal that landed her a five-month stint in federal prison. Back in December 2001, Stewart sold her 3,928-share stake in the biopharmaceutical company, ImClone Systems, which was owned by her close friend, Sam Waksal. On the surface, there's nothing illegal about selling shares. However, in 2002, federal authorities questioned Stewart about why she sold when she did."
Martha Stewart built a vast lifestyle empire after beginning her career as a model and stockbroker, becoming America's first female self-made billionaire in 1999. Major controversies have punctuated that success, with the most prominent being the insider trading case tied to her sale of ImClone Systems shares in December 2001. Federal inquiries focused on tips from her broker and links to ImClone owner Sam Waksal after the FDA refused to review a cancer drug. The resulting legal fallout included SEC scrutiny and a five-month federal prison sentence in 2004. Additional controversies involve family tensions, extramarital affairs, questionable friendships, and other financial transgressions.
Read at Tasting Table
Unable to calculate read time
[
|
]